HIV Interventions: Biomedicine and the Traffic between Information and Flesh

Bibliography

131 Abraham, J., and G. Lewis. “The Secrecy and Transparency of Medicines Licensing in the EU.” The Lancet 352, no. 9126 (8 August 1998): 480–82. Adam, B. “Constructing the Neoliberal Sexual Actor.” Culture, Health & Sexuality 7, no. 4 (2005): 333–46. ———. “Infection Behaviour: Imputing Subjectivity to HIV transmission.” Social Theory & Health 4 (2006): 168–79. Adkins, L. “Objects of Innovation: Post-occupational Reflexivity and Re-traditionalisations of Gender.” In Transformations: Thinking Through Feminism, edited by S. Ahmed, J. Kilby, C. Lury, M. McNeil, and B. Skeggs. New York and London: Routledge, 2000. AIDS Action Council of New South Wales. “there isn’t room for ambiguity,” http:// www.aidsaction.org.au/content/events/reflections/there_isnt_room_for_ambi guity.php, 1992. AIDS Vaccine Advocacy Coalition (AVAC). “Will a Pill a Day Prevent HIV? Anticipating the Results of ‘PREP’ Trials.” New York: AVAC AIDS Vaccine Advocacy Coalition, 2005. Alcorn, K., and R. Fieldhouse. AIDS Reference Manual. London: NAM Publications, 2000. An, P., M. P. Martin, G. W. Nelson, M. Carrington, M. W. Smith, K. Gong, D. Vlahov , S. J. O’Brien, and C. A. Winkler. “Influence of CCR5 Promoter Haplotypes on AIDS Progression in African-Americans.” AIDS 14 (2000): 2117–22. Anderson, W., and P. Weatherburn. Taking Heart? The Impact of Combination Therapy on the Lives of People with HIV (Phase 2). London: Sigma Research, 1999. Attili, V. S. S., S. Sundar, V. P. Singh, and M. Rai. “Validity of Existing CD4+ Classification in North Indians, in Predicting Immune Status.” Journal of Infection 51 (2002): 41–46. AVERT an international AIDS charity: http://www.avert.org/aids-africaquestions -2.htm. Bangsberg, D. R., A. R. Moss, and S. G. Deeks. “Paradoxes of Adherence and Drug Resistance to HIV Antiretroviral Therapy.” Journal of Antimicrobial Chemotherapy 53 (2004): 696–99. Barad, K. “Getting Real: Technoscientific Practices and the Materialization of Reality .” differences: A Journal of Feminist Cultural Studies 10, no. 2 (1998): 87–128. Bibliography 132 Bibliography Barnett, T., and A. Whiteside. AIDS in the Twenty-First Century: Disease and Globalization , 2nd ed. Basingstoke, UK: Palgrave Macmillan, 2006. Barry, A. “Pharmaceutical Matters: The Invention of Informed Materials.” In “Inventive Life: Approaches Towards a New Vitalism,” special issue edited by M. Fraser, S. Kember, and C. Lury, Theory, Culture & Society 22, no. 1 (2005): 51–69. Bieniasz, P. New Insights into Retrovirus-host-cell Interactions. 15th Conference on Retroviruses and Opportunistic Infections, Boston, abstract 114, 2008. Birke, L., A. Arluke, and M. Michael. The Sacrifice: How Scientific Experiments Transform Animals and People. West Lafayette, IN: Purdue University Press, 2006. BBC News. “Drug Simplifies Living with HIV. ”16 January 2001, http://news.bbc. co.uk/hi/english/health/newsid_1119000/1119634.stm. Bristol-Myers Web site. http://www.bms.com/aboutbms/data. British HIV Association. “British HIV Association (BHIVA) Guidelines for the Treatment of HIV-1-Infected Adults with Antiretroviral Therapy.” HIV Medicine 9 (2008): 563–608. Burchard, E. B., E. Ziv, N. Coyle, S. L. Gomez, et al. “The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice.” New England Journal of Medicine 348, no. 12 (2003): 1170–76. Butler, J. Bodies That Matter: On the Discursive Limits of Sex. New York and London: Routledge, 1993. ———. Gender Trouble: Feminism and the Subversion of Identity. New York and London: Routledge, 1990. ———. Psychic Power of Life: Theories in Subjection. Stanford, CA: Stanford University Press, 1997. ———. “Sexual Inversions.” In Discourses of Sexuality: From Aristotle to AIDS, edited by D. Stanton. Ann Arbor: University of Michigan Press, 1992. Callon, M., C. Mèadel, and V. Rabeharisoa. “The Economy of Qualities.” Economy and Society 31, no. 2 (2002): 194–217. Cameron, E., with contributions by N. Geffen. Witness to AIDS. Capetown: Tafelberg, 2005. CASCADE Collaboration. “Differences in CD4 Cell Counts at Seroconversion and Decline Among 5739 HIV-1-Infected Individuals with Well-Estimated Dates of Seroconversion.” Journal of Acquired Immune Deficiency Syndrome 34, no. 1 (2003): 76–83. CDC (Communicable Disease Surveillance Centre). “Changes in the Incidence of AIDS and in AIDS Deaths: The Effects of Antiretroviral Treatment.” CDR 7 (1997): 381. CDC (Centers for Disease Control and Prevention). “What Is HIV?” http://www.cdc. gov/hiv/resources/qa/qa1.htm. Chase, C. “Hermaphrodites with Attitude: Mapping the Emergence of Intersex Political Activism.” GLQ: A Journal of Lesbian and Gay Studies 4, no. 2 (1998): 189–211. Bibliography 133 Check, E. “Hunt for AIDS Vaccine Tackles Genomes.” Nature 441 (2006): 1034–35. Chen, S. Y., S. Gibson, and...